In this edition of Null and Noteworthy, scientists find little to be excited about in research on biomarkers for neurodevelopmental conditions.

The COVID-19 pandemic forced a reckoning, in which autism clinicians had to redefine best practices and expand how children are evaluated. The remote assessments they developed may help solve a persistent problem: the long wait families endure to get a diagnosis in the United States.

The dual diagnosis frequently co-occurs with anxiety, depression and developmental and language delays.

Elsevier’s retractions focus on peer review and conflicts of interest.

The measure breaks the behaviors down into eight distinct subdomains — categorization that could prove useful for clinical trials, its creator says.

A new gene therapy approach for epilepsy tamps down neural activity on demand.

New studies bolster the idea that zebrafish models can say something meaningful about social behavior in autism.

Brain scans of the hippocampus reveal autistic people who are at increased risk of cognitive problems as they get older.

A range of presentations at Neuroscience 2022 tie atypical social behavior to trouble discriminating between odors in the animals.

Scott describes his work on sound processing differences in the brains of zebrafish that model fragile X syndrome.